6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
30m ago	Amazon Launches Amazon Supply Chain Services, Opening Its Logistics Network to All Businesses
57m ago	Go Metals Produces Premium "Green Iron" Concentrate with Vanadium Credit and High-Grade TiO2 Ilmenite from Bench-scale Testing and Announces Private Placement
57m ago	Ambarella Announces First Quarter Fiscal Year 2027 Earnings Conference Call to be Held May 28, 2026
58m ago	Vmoto Signs Global MotoGP Deal for Electric Scooters
1h ago	Espire Hospitality Limited expands its uber-luxury portfolio by entering into an agreement with Marriott International to manage its upcoming 'JW Marriott Resort & Spa' near Vrindavan

About

Rein Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock

Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis

Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis

Rein Therapeutics Receives Orphan Drug Designation from European Medicines Agency for Lead Drug Candidate in Idiopathic Pulmonary Fibrosis

Rein Therapeutics Announces New Scientific Publication Demonstrating LTI-03 May Reduce Lung Scarring and Protect Cells Needed for Lung Repair in IPF

How Rein Therapeutics, Inc. runs its investor program on 6ix — audience, formats, and program overview.

Recent Videos

Rein Therapeutics: A New Hope for IPF #PulmonaryFibrosis #InnovativeMedicine

Rein Therapeutics: A New Hope for IPF #PulmonaryFibrosis #InnovativeMedicine

Apr 01, 2026

Reining in Fibrosis: The Story Behind Our Name

Reining in Fibrosis: The Story Behind Our Name

Mar 19, 2026

How to Invest in Rein Therapeutics Inc (RNTX) Step by Step

How to Invest in Rein Therapeutics Inc (RNTX) Step by Step

Feb 25, 2026

Respiratory Update – 23 January, 2026: Krystal Biotech CFTR, Kinaset’s $103M for Asthma and more

Respiratory Update – 23 January, 2026: Krystal Biotech CFTR, Kinaset’s $103M for Asthma and more

Jan 23, 2026

Community Chat

Ask AI